Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Total Liabilities: 2013-2018

Historic Total Liabilities for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2018 value amounting to $12.7 million.

  • Soleno Therapeutics' Total Liabilities fell 16.78% to $13.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $13.8 million, marking a year-over-year decrease of 16.78%. This contributed to the annual value of $12.7 million for FY2018, which is 4.37% up from last year.
  • Per Soleno Therapeutics' latest filing, its Total Liabilities stood at $12.7 million for FY2018, which was up 4.37% from $12.2 million recorded in FY2017.
  • Soleno Therapeutics' 5-year Total Liabilities high stood at $19.6 million for FY2014, and its period low was $2.1 million during FY2016.
  • For the 3-year period, Soleno Therapeutics' Total Liabilities averaged around $9.0 million, with its median value being $12.2 million (2017).
  • Per our database at Business Quant, Soleno Therapeutics' Total Liabilities plummeted by 74.59% in 2015 and then surged by 473.10% in 2017.
  • Yearly analysis of 5 years shows Soleno Therapeutics' Total Liabilities stood at $19.6 million in 2014, then plummeted by 74.59% to $5.0 million in 2015, then crashed by 57.21% to $2.1 million in 2016, then surged by 473.10% to $12.2 million in 2017, then grew by 4.37% to $12.7 million in 2018.